Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Avoid perpetuating inequities when managing gout in the setting of COVID-19
+Print Archive
PRACTICE
Avoid perpetuating inequities when managing gout in the setting of COVID-19
Wednesday 22 April 2020, 01:00 AM
Avoiding kaimoana is culturally inappropriate to some people and may not be necessary if gout is well managed
PHARMACOTHERAPY
Gout is the most common inflammatory arthritis in New Zealand, but medicines are available to manage and prevent it. This article presents the treatment options available and discusses how COVID-19 might affect prescribing decisions
Leanne Te Karu and Linda Bryant
There is debate and a lack of clear evidence around the use of prednisone (immunosuppression) and NSAIDs (impact on renal and cardiovascular disease)
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.